Oestrogenic effects of adjuvant tamoxifen in postmenopausal breast cancer

This publication has 39 references indexed in Scilit:

• Anti-oestrogenic and anti-tumour properties of prolonged tamoxifen therapy in C3H/OUJ mice
  European Journal of Cancer and Clinical Oncology, 1990
• ADJUVANT TAMOXIFEN AND SECOND CANCERS
  The Lancet, 1989
• A Randomized Clinical Trial Evaluating Tamoxifen in the Treatment of Patients with Node-Negative Breast Cancer Who Have Estrogen-Receptor–Positive Tumors
  New England Journal of Medicine, 1989
• Adjuvant tamoxifen in primary breast cancer: Influence on plasma lipids and antithrombin III levels
  Breast Cancer Research and Treatment, 1988
• Effects of anti-estrogens on bone in castrated and intact female rats
  Breast Cancer Research and Treatment, 1987
• The effect of tamoxifen on plasma growth hormone and prolactin in postmenopausal women with advanced breast cancer
  European Journal of Cancer and Clinical Oncology, 1983
• The biology and physiology of ‘Nolvadex’ (tamoxifen) in the treatment of breast cancer
  Breast Cancer Research and Treatment, 1982
• Estrogen-Like Action of Tamoxifen on Vaginal Epithelium in Breast Cancer Patients
  Oncology, 1981
• PROLONGED OESTROGENIC AND MITOGENIC ACTIVITY OF TAMOXIFEN IN THE OVARIECTOMIZED MOUSE
  Journal of Endocrinology, 1978
• 243. Antitumour activity of the antiestrogen ICI 46,474 (Tamoxifen) in the dimethylbenzanthracene (DMBA)—induced rat mammary carcinoma model
  Journal of Steroid Biochemistry, 1974